Kyndryl Securities Fraud Lawsuits
Analysis based on 22 articles · First reported Apr 01, 2026 · Last updated Apr 13, 2026
The market is negatively impacted by the alleged securities fraud by Kyndryl, leading to a significant drop in its share price. The ongoing class-action lawsuits by firms like Kahn Swick & Foti and Rosen Law Firm create uncertainty for investors and highlight the importance of corporate governance and financial reporting accuracy.
Kyndryl is facing multiple class-action securities lawsuits from law firms such as Kahn Swick & Foti and Rosen Law Firm. These lawsuits allege that Kyndryl made false and misleading statements and failed to disclose material information between August 1, 2024, and February 9, 2026. The core of the allegations stems from Kyndryl's announcement on February 9, 2026, that it would be unable to timely file its Form 10-Q Report for the quarter ended December 31, 2025. The company also anticipated reporting material weaknesses in its internal control over financial reporting for multiple fiscal periods, alongside the departure of its CFO and General Counsel. This news caused Kyndryl's shares to fall by $12.90 per share, or 55%, closing at $10.59 on February 9, 2026. Investors who suffered losses during this period have until April 13, 2026, to apply to be lead plaintiffs in these lawsuits.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard